Hosted on MSN13d
What To Know About HR+/HER2- Breast Cancer
HR+/HER2- breast cancer—or hormone receptor-positive, HER2-negative breast cancer—is the most common subtype of ...
News Medical on MSN38m
IgE antibodies show promise in targeting HER2 cancers resistant to other therapies
Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
Targeted Oncology10h
HER2DX Test Transforms Treatment Decisions in HER2+ Breast Cancer
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
Triple-Negative Breast Cancer (TNBC): Understanding Diagnosis and Treatment
TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
Where Does Breast Cancer Most Commonly Spread?
The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...
WebMD12d
Treatment for HER2-Negative Advanced Breast Cancer
When you have HER2-negative advanced (metastatic) breast cancer, treatment usually focuses on managing your disease, not curing the cancer. The goal is to help you live longer and have a ...
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the enrollment of the ...
On Her Mind: State representative working to close gaps in women's healthcare while battling breast cancer
Less than two months ago, 52-year-old Oklahoma State Representative Melissa Provenzano underwent a mastectomy for stage one ...